Abstract
Alcohol withdrawal is associated with hypothalamic–pituitary–adrenal (HPA) axis dysfunction. The FKBP5 gene codes for a co-chaperone, FK506-binding protein 5, that exerts negative feedback on HPA axis function. This study aimed to examine the effects of single-nucleotide polymorphisms (SNPs) of the FKBP5 gene in humans and the effect of Fkbp5 gene deletion in mice on alcohol withdrawal severity. We genotyped six FKBP5 SNPs (rs3800373, rs9296158, rs3777747, rs9380524, rs1360780, and rs9470080) in 399 alcohol-dependent inpatients with alcohol consumption 48 h before admission and recorded scores from the Clinical Institute Withdrawal Assessment-Alcohol revised (CIWA-Ar). Fkbp5 gene knockout (KO) and wild-type (WT) mice were assessed for alcohol withdrawal using handling-induced convulsions (HICs) following both acute and chronic alcohol exposure. We found the minor alleles of rs3800373 (G), rs9296158 (A), rs1360780 (T), and rs9470080 (T) were significantly associated with lower CIWA-Ar scores whereas the minor alleles of rs3777747 (G) and rs9380524 (A) were associated with higher scores. The haplotype-based analyses also showed an association with alcohol withdrawal severity. Fkbp5 KO mice showed significantly greater HICs during withdrawal from chronic alcohol exposure compared with WT controls. This study is the first to show a genetic effect of FKBP5 on the severity of alcohol withdrawal syndrome. In mice, the absence of the Fkbp5 gene enhances sensitivity to alcohol withdrawal. We suggest that FKBP5 variants may trigger different adaptive changes in HPA axis regulation during alcohol withdrawal with concomitant effects on withdrawal severity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Adinoff B, Iranmanesh A, Veldhuis J, Fisher L (1998). Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World 22: 67–72.
Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S (2005). Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 29: 1351–1355.
Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G (1978). A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl 271: 5–27.
Attwood BK, Bourgognon JM, Patel S, Mucha M, Schiavon E, Skrzypiec AE et al (2011). Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 473: 372–375.
Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
Becker HC (2012). Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption. Alcohol Res 34: 448–458.
Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 57: 289–300.
Bevilacqua L, Carli V, Sarchiapone M, George DK, Goldman D, Roy A et al (2012). Interaction between FKBP5 and childhood trauma and risk of aggressive behavior. Arch Gen Psychiatry 69: 62–70.
Binder EB (2009). The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34 (Suppl 1): S186–S195.
Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB et al (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299: 1291–1305.
Binder EB, Kunzel HE, Nickel T, Kern N, Pfennig A, Majer M et al (2009). HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 34: 99–109.
Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36: 1319–1325.
Brent D, Melhem N, Ferrell R, Emslie G, Wagner KD, Ryan N et al (2010). Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry 167: 190–197.
Costa A, Bono G, Martignoni E, Merlo P, Sances G, Nappi G (1996). An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology 21: 263–275.
Du Y, Nie Y, Li Y, Wan YJ (2011). The association between the SLC6A3 VNTR 9-repeat allele and alcoholism-A meta-analysis. Alcohol Clin Exp Res 35: 1625–1634.
Esel E, Sofuoglu S, Aslan SS, Kula M, Yabanoglu I, Turan MT (2001). Plasma levels of beta-endorphin, adrenocorticotropic hormone and cortisol during early and late alcohol withdrawal. Alcohol Alcohol 36: 572–576.
First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. American Psychiatric Press: Washington, DC.
Heilig M, Egli M, Crabbe JC, Becker HC (2010). Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol 15: 169–184.
Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA et al (2008). Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43: 505–515.
Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S et al (2008). Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 28: 389–398.
Karpyak VM, Biernacka JM, Weg MW, Stevens SR, Cunningham JM, Mrazek DA et al (2010). Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremens. Addict Biol 15: 23–34.
Karpyak VM, Kim JH, Biernacka JM, Wieben ED, Mrazek DA, Black JL et al (2009). Sequence variations of the human MPDZ gene and association with alcoholism in subjects with European ancestry. Alcohol Clin Exp Res 33: 712–721.
Kendler KS, Aggen SH, Prescott CA, Crabbe J, Neale MC (2012). Evidence for multiple genetic factors underlying the DSM-IV criteria for alcohol dependence. Mol Psychiatry 17: 1306–1315.
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM et al (2013). Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16: 33–41.
Koehnke MD, Schick S, Lutz U, Willecke M, Koehnke AM, Kolb W et al (2002). Severity of alcohol withdrawal symptoms and the T1128C polymorphism of the neuropeptide Y gene. J Neural Transm 109: 1423–1429.
Limosin F, Loze JY, Boni C, Fedeli LP, Hamon M, Rouillon F et al (2004). The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neurosci Lett 362: 91–94.
McClintick JN, Xuei X, Tischfield JA, Goate A, Foroud T, Wetherill L et al (2013). Stress-response pathways are altered in the hippocampus of chronic alcoholics. Alcohol 47: 505–515.
Metten P, Crabbe JC (1994). Common genetic determinants of severity of acute withdrawal from ethanol, pentobarbital and diazepam in inbred mice. Behav Pharmacol 5: 533–547.
Metten P, Crabbe JC (2005). Alcohol withdrawal severity in inbred mouse (Mus musculus) strains. Behav Neurosci 119: 911–925.
Okubo T, Harada S, Higuchi S, Matsushita S (2003). Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms. Alcohol Clin Exp Res 27: 68S–71S.
Perez-Ortiz JM, Garcia-Gutierrez MS, Navarrete F, Giner S, Manzanares J (2013). Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology 38: 1251–1258.
Preuss UW, Zill P, Koller G, Bondy B, Hesselbrock V, Soyka M (2006). Ionotropic glutamate receptor gene GRIK3 SER310ALA functional polymorphism is related to delirium tremens in alcoholics. Pharmacogenomics J 6: 34–41.
Roberts AJ, Crabbe JC, Keith LD (1994). Corticosterone increases severity of acute withdrawal from ethanol, pentobarbital, and diazepam in mice. Psychopharmacology 115: 278–284.
Rose AK, Shaw SG, Prendergast MA, Little HJ (2010). The importance of glucocorticoids in alcohol dependence and neurotoxicity. Alcohol Clin Exp Res 34: 2011–2018.
Roy A, Gorodetsky E, Yuan Q, Goldman D, Enoch MA (2010). Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35: 1674–1683.
Rujescu D, Soyka M, Dahmen N, Preuss U, Hartmann AM, Giegling I et al (2005). GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal. Am J Med Genet B Neuropsychiatr Genet 133B: 85–87.
Schafer I, Teske L, Schulze-Thusing J, Homann K, Reimer J, Haasen C et al (2010). Impact of childhood trauma on hypothalamus-pituitary-adrenal axis activity in alcohol-dependent patients. Eur Addict Res 16: 108–114.
Schmidt LG, Sander T (2000). Genetics of alcohol withdrawal. Eur Psychiatry 15: 135–139.
Schumann G, Rujescu D, Kissling C, Soyka M, Dahmen N, Preuss UW et al (2003). Analysis of genetic variations of protein tyrosine kinase fyn and their association with alcohol dependence in two independent cohorts. Biol Psychiatry 54: 1422–1426.
Sharrett-Field L, Butler TR, Berry JN, Reynolds AR, Prendergast MA (2013). Mifepristone pretreatment reduces ethanol withdrawal severity in vivo. Alcohol Clin Exp Res 37: 1417–1423.
Shirley RL, Walter NA, Reilly MT, Fehr C, Buck KJ (2004). Mpdz is a quantitative trait gene for drug withdrawal seizures. Nat Neurosci 7: 699–700.
Skinner H, Horn J (1984). Alcohol Dependence Scale: User’s Guide. Addiction Research Foundation: Toronto, Canada.
Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS et al (2008). Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry 63: 139–145.
Stephens MA, Wand G (2012). Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res 34: 468–483.
Tadic A, Dahmen N, Szegedi A, Rujescu D, Giegling I, Koller G et al (2005). Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens. Eur Arch Psychiatry Clin Neurosci 255: 129–135.
Tatro ET, Nguyen TB, Bousman CA, Masliah E, Grant I, Atkinson JH et al (2010). Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in human immunodeficiency virus-infected individuals. J Neurovirol 16: 399–404.
van Munster BC, Korevaar JC, de Rooij SE, Levi M, Zwinderman AH (2007). Genetic polymorphisms related to delirium tremens: a systematic review. Alcohol Clin Exp Res 31: 177–184.
Velders FP, Kuningas M, Kumari M, Dekker MJ, Uitterlinden AG, Kirschbaum C et al (2011). Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology 36: 1053–1061.
Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield TW Jr., Logrip ML et al (2012). Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci 32: 7563–7571.
Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M (2003). Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 88: 277–284.
Wernicke C, Samochowiec J, Schmidt LG, Winterer G, Smolka M, Kucharska-Mazur J et al (2003). Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits. Biol Psychiatry 54: 922–928.
Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T (2005). FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280: 4609–4616.
Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Farrer LA et al (2010). Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35: 1684–1692.
Yong W, Yang Z, Periyasamy S, Chen H, Yucel S, Li W et al (2007). Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology. J Biol Chem 282: 5026–5036.
Zannas AS, Binder EB (2014). Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism. Genes Brain Behav 13: 25–37.
Acknowledgements
We thank Matthew S Powers, Kristen R Breit, Monte Phillips, Hui Sun, and Judy Powers for providing technical assistance on this project. We also express our appreciation to Drs Weinian Shou and Weidong Yong for their support on animal breeding and valuable discussions over this research.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Rights and permissions
About this article
Cite this article
Huang, MC., Schwandt, M., Chester, J. et al. FKBP5 Moderates Alcohol Withdrawal Severity: Human Genetic Association and Functional Validation in Knockout Mice. Neuropsychopharmacol 39, 2029–2038 (2014). https://doi.org/10.1038/npp.2014.55
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2014.55
This article is cited by
-
FKBP5 inhibitors modulate alcohol drinking and trauma-related behaviors in a model of comorbid post-traumatic stress and alcohol use disorder
Neuropsychopharmacology (2023)
-
Alcohol-specific transcriptional dynamics of memory reconsolidation and relapse
Translational Psychiatry (2023)
-
FKBP51 modulates hippocampal size and function in post-translational regulation of Parkin
Cellular and Molecular Life Sciences (2022)
-
Genetic association of FKBP5 with trait resilience in Korean male patients with alcohol use disorder
Scientific Reports (2021)
-
Analysis of whole genome-transcriptomic organization in brain to identify genes associated with alcoholism
Translational Psychiatry (2019)
